Activating pyruvate kinase R
US-12122778-B2 · Oct 22, 2024 · US
This page is not indexed by search engines while we improve data quality.
Mitchell Lorna patents
Mitchell Lorna is listed as an inventor on 28 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mitchell Lorna |
| Total patents | 28 |
| First publication | Feb 19, 2019 |
| Latest publication | Oct 22, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-12071440-B2 · Aug 27, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2024083901-A1 · Mar 14, 2024 · US
Activating pyruvate kinase R
US-11844787-B2 · Dec 19, 2023 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11649242-B2 · May 16, 2023 · US
Activating pyruvate kinase r
US-2023055923-A1 · Feb 23, 2023 · US
Compositions for activating pyruvate kinase
US-11396513-B2 · Jul 26, 2022 · US
Activating pyruvate kinase r
US-2022087983-A1 · Mar 24, 2022 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2022031671-A1 · Feb 3, 2022 · US
Activating pyruvate kinase r
US-2021308108-A1 · Oct 7, 2021 · US
Recent patents
Latest publications not already listed above.
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2021246143-A1 · Aug 12, 2021 · US
Activating pyruvate kinase R
US-11071725-B2 · Jul 27, 2021 · US
Activating pyruvate kinase r and mutants thereof
US-2021221816-A1 · Jul 22, 2021 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11014927-B2 · May 25, 2021 · US
Activating pyruvate kinase R and mutants thereof
US-11001588-B2 · May 11, 2021 · US
Compositions for activating pyruvate kinase
US-2021017184-A1 · Jan 21, 2021 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2020405699-A1 · Dec 31, 2020 · US
Compositions for activating pyruvate kinase
US-10836771-B2 · Nov 17, 2020 · US
Activating pyruvate kinase r
US-2020253939-A1 · Aug 13, 2020 · US
Activating pyruvate kinase R
US-10675274-B2 · Jun 9, 2020 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2020129485-A1 · Apr 30, 2020 · US
Activating pyruvate kinase r and mutants thereof
US-2020087309-A1 · Mar 19, 2020 · US
Activating pyruvate kinase r
US-2020085798-A1 · Mar 19, 2020 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2020069643-A1 · Mar 5, 2020 · US
Compositions for activating pyruvate kinase
US-2020031839-A1 · Jan 30, 2020 · US
Compositions for activating pyruvate kinase
US-10472371-B2 · Nov 12, 2019 · US
Compositions for activating pyruvate kinase
US-2019218221-A1 · Jul 18, 2019 · US
Compositions for activating pyruvate kinase
US-10208052-B1 · Feb 19, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Forma Therapeutics Inc | 25 |
| Novo Nordisk Healthcare Ag | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K9/0053 | 27 |
| C07D487/04 | 27 |
| A61K31/436 | 23 |
| A61K31/407 | 18 |
| A61P7/00 | 14 |